PMLiVE The whistleblower cases focus on activities related to Novartis' immunosuppressant product Myfortic (mycophenolate), antihypertensives Lotrel (almodipine and benazepril) and Valturna (aliskiren and valsartan ), and the diabetes treatment Starlix ...
Truthdig In a news release last week, the department said the company paid physicians to talk about three Novartis medications—hypertension drugs amlodipine/benazepril (Lotrel) and aliskiren/ valsartan (Valturna) and diabetes drug nateglinide (Starlix). The ... and more »
Insider Monkey (blog) Interestingly, the companies also used a similar naming situation (ending the drugs in -or) for many of the brand names as well: Pfizer Inc. (NYSE:PFE)'s Lipitor ( atorvastatin ), Merck & Co., Inc. (NYSE:MRK)'s Zocor (simvastatin), and AstraZeneca plc ...
